These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 2938016)

  • 1. Requirement for c-ras proteins during viral oncogene transformation.
    Smith MR; DeGudicibus SJ; Stacey DW
    Nature; 1986 Apr 10-16; 320(6062):540-3. PubMed ID: 2938016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of cellular ras proteins in proliferative signal transduction.
    Stacey DW; Tsai MH; Yu CL; Smith JK
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():871-81. PubMed ID: 3076101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
    Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
    Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
    Papageorge A; Lowy D; Scolnick EM
    J Virol; 1982 Nov; 44(2):509-19. PubMed ID: 6292515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.
    Mulcahy LS; Smith MR; Stacey DW
    Nature; 1985 Jan 17-23; 313(5999):241-3. PubMed ID: 3918269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity.
    Satoh T; Endo M; Nakafuku M; Akiyama T; Yamamoto T; Kaziro Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7926-9. PubMed ID: 2146678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.
    Feig LA; Cooper GM
    Mol Cell Biol; 1988 Aug; 8(8):3235-43. PubMed ID: 3145408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
    Ridley AJ; Paterson HF; Noble M; Land H
    EMBO J; 1988 Jun; 7(6):1635-45. PubMed ID: 3049071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells.
    Gallego C; Gupta SK; Heasley LE; Qian NX; Johnson GL
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7355-9. PubMed ID: 1323832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
    Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
    Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
    Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.
    Feramisco JR; Clark R; Wong G; Arnheim N; Milley R; McCormick F
    Nature; 1985 Apr 18-24; 314(6012):639-42. PubMed ID: 2581140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function.
    Srivastava SK; Lacal JC; Reynolds SH; Aaronson SA
    Mol Cell Biol; 1985 Nov; 5(11):3316-9. PubMed ID: 3915772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
    Agazie Y; Ischenko I; Hayman M
    Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.